Category: Agilent Dako

Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell...

Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial...

Agilent Names John Palma to Lead Global Medical Affairs Organization Agilent Technologies, Inc. (NYSE: A) today...

Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric,...

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast...

Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement Agilent Technologies Inc. (NYSE: A)...

Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer PD-L1 IHC 22C3 pharmDx can now...

Clinical Utility of ALK Fusion Detection by Liquid Biopsy Cell-free DNA NGS detects common and novel ALK fusions in...

Cell-Free DNA Guided Targeted Therapy Leads to Better Survival in Advanced Non-Small Cell Lung Cancer MSK and...

Agilent Announces Cash Dividend of 19.4 Cents per Share Agilent Technologies, Inc. (NYSE: A) today announced that a...